Trans-Cinnamaldehyde Composition for Resistant Bacterial Infections
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The increasing prevalence of resistant bacterial strains, particularly in hospital settings, poses a significant challenge as conventional antibacterial agents are rendered ineffective by mechanisms of resistance, necessitating the development of novel antibacterial molecules with broad-spectrum activity against both Gram-positive and Gram-negative bacteria.
Innovation Solution
A composition comprising trans-cinnamic aldehyde, potentially combined with other compounds like trans-2-methoxycinnamaldehyde, cinnamyl acetate, coumarin, linalool, beta-caryophyllene, and eugenol, is used to create an antibacterial agent that exhibits strong activity against resistant bacterial strains, including those resistant to traditional antibiotics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibacterial agents are used, then initial treatment effectiveness is achieved, but bacterial resistance develops rapidly rendering the agents ineffective
Solution Approach 1:
The patent changes the chemical structure parameter by using trans-cinnamaldehyde (an aromatic aldehyde) instead of conventional antibacterial agents. This structural parameter change results in novel antibacterial activity against resistant strains while maintaining effectiveness over extended periods without inducing resistance mechanisms.
Solution Approach 2:
The patent employs a composite approach by combining trans-cinnamaldehyde with other compounds (trans-2-methoxycinnamaldehyde, cinnamyl acetate, coumarin, linalool, beta-caryophyllene, eugenol) to create a multi-component composition. This composite formulation enhances broad-spectrum activity against both Gram-positive and Gram-negative bacteria while preventing resistance development through multiple mechanisms of action.
2Reliability
If new antibacterial molecules are developed to overcome resistance, then activity against resistant strains is improved, but the risk of inducing new resistance mechanisms increases
Solution Approach 1:
The patent uses trans-cinnamaldehyde as an intermediary substance that disrupts bacterial cell membranes and inhibits essential enzymes. This intermediary mechanism of action is sufficiently different from conventional antibiotics that it overcomes existing resistance mechanisms while the natural metabolism of bacteria provides a buffer against rapid resistance development.
Solution Approach 2:
The composition achieves universal antibacterial activity against both Gram-positive and Gram-negative bacteria, as well as fungi and viruses. This multi-functionality is accomplished through the synergistic combination of multiple compounds that target different bacterial structures and metabolic pathways, reducing the likelihood of resistance development through any single mechanism.
3Reliability
If high concentrations of antibacterial agents are used to ensure effectiveness, then immediate bactericidal activity is achieved, but toxicity to host tissues increases
Solution Approach 1:
The patent changes the concentration parameter by achieving effective bactericidal activity at low concentrations (MIC values in the range of 0.06-2.5% v/v) compared to conventional antibiotics. This is accomplished through the inherent potency of trans-cinnamaldehyde and its synergistic interactions with co-formulated compounds, which enhance microbial cell membrane disruption and enzyme inhibition while maintaining selectivity for microbial over host cells.
Data Source
AI summary
The present invention relates to a composition, in particular an antibacterial drug, including trans-cinnamaldehyde, a pharmaceutical composition including trans-cinnamaldehyde for treatment or prevention, in particular, of a nosocomial infection, specifically caused by a bacteria resistant to anti-bacterial drugs, the use of trans-cinnamaldehyde as an anti-bacterial agent and a method for preparing a surface including the application of a composition according to the invention.